Pharmacology News

Patients prescribed buprenorphine at 24 mg for opioid use disorder were more likely to remain in treatment compared with those prescribed a 16 mg dose, a study in JAMA Network Open showed.

Researchers observed an increase in antibiotic prescribing for respiratory tract infections in winter vs. summer months — likely driven in part by inappropriate prescribing.

Seeing how much a medication would cost a patient helped some physicians make decisions when prescribing, according to the results of research published in JAMA Internal Medicine.

SAN DIEGO — A growing body of clinical trial data are increasingly guiding the treatment landscape for giant cell and Takayasu arteritis, according to a presenter at the 2023 Congress of Clinical Rheumatology West.

The implementation of CancelRx was associated with “an immediate and persistent reduction in the proportion of e-prescriptions” that were sold after they had been discontinued in electronic health records, according to researchers.

HHS announced the first 10 drugs that will be subject to Medicare price negotiations.

Switching older patients with frailty syndrome and atrial fibrillation to a non-vitamin K antagonist from their old blood thinner caused significant bleeding risk and no greater protection from stroke, a speaker reported.

In adults with HF with preserved ejection fraction and obesity, semaglutide 2.4 mg significantly improved HF-related symptoms and physical limitations and was associated with greater weight loss compared with placebo, researchers reported.

Adults with overweight or obesity had a 10% annual probability of achieving 5% or greater weight loss, according to study data published in JAMA Network Open.

Aspirin is underused for secondary CVD prevention worldwide, particularly in lower-income countries, researchers reported in JAMA.